Maternal haemodynamic function differs in pre‐eclampsia when it is associated with a small‐for‐gestational‐age newborn: a prospective cohort study

  1. Gutierrez, J 2
  2. Perry, H 12
  3. Binder, J 34
  4. Thilaganathan, B 12
  5. Khalil, A 12
  1. 1 Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute St George's University of London London UK
  2. 2 Fetal Medicine Unit Department of Obstetrics and Gynaecology St George's University Hospitals NHS Foundation Trust London UK
  3. 3 Department of Obstetrics and Feto‐maternal Medicine Medical University of Vienna Vienna Austria
  4. 4 Fetal Medicine Unit Department of Obstetrics and Gynaecology Medical University of Vienna Vienna Austria
Zugehörigkeit anzeigen +
Zeitschrift:
BJOG: An International Journal of Obstetrics & Amp; Gynaecology

ISSN: 1470-0328,  1471-0528

Datum der Publikation: 2020

Ausgabe: 128

Nummer: 2

Seiten: 167-175

Art: Artikel

DOI: 10.1111/1471-0528.16269 GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: BJOG: An International Journal of Obstetrics & Amp; Gynaecology

Zusammenfassung

Objective To describe maternal haemodynamic differences in gestational hypertension with small-for-gestational-age babies (HDP + SGA), gestational hypertension with appropriate-for- gestational-age babies (HDP-only) and control pregnancies.Design Prospective cohort study.Setting Tertiary Hospital, UK.Population Women with gestational hypertension and healthy pregnant women.Methods Maternal haemodynamic indices were measured using a non-invasive Ultrasound Cardiac Output Monitor (USCOM-1A®) and corrected for gestational age and maternal characteristics using device-specific reference ranges.Main outcome measures Maternal cardiac output, stroke volume, systemic vascular resistance.Results We included 114 HDP + SGA, 202 HDP-only and 401 control pregnancies at 26–41 weeks of gestation. There was no significant difference in the mean arterial blood pressure (110 versus 107 mmHg, P = 0.445) between the two HDP groups at presentation. Pregnancies complicated by HDP + SGA had significantly lower median heart rate (76 versus 85 bpm versus 83 bpm), lower cardiac output (0.85 versus 0.98 versus0.97MoM) and higher systemic vascular resistance (1.4 versus 1.0 versus 1.2 MoM) compared with control and HDP-only pregnancies, respectively (all P < 0.05).Conclusion Women with HDP + SGA present with more severe haemodynamic dysfunction than HDP-only. Even HDP-only pregnancies exhibit impaired haemodynamic indices compared with normal pregnancies, supporting a role of the maternal cardiovascular system in gestational hypertension irrespective of fetal size. Central haemodynamic changes may play a role in the pathogenesis of pre-eclampsia and should be considered alongside placental aetiology.Keywords Cardiac output, heart rate, hypertension, maternal haemodynamics, non-invasive monitoring, pre-eclampsia, small for gestational age, systemic vascular resistance.Tweetable abstract Hypertensive disorders of pregnancy are associated with worse maternal haemodynamic function when associated with small-for-gestational-age birth.Linked article This article is commented on by H Valensise,p. 176 in this issue. To view this mini commentary visit https:// doi.org/10.1111/1471-0528.16317.

Bibliographische Referenzen

  • 10.1016/j.ajog.2005.10.813
  • Egeland GM, (1979), Hypertens (Dallas, Tex, 2016, pp. 1173
  • 10.1016/j.ajog.2014.07.055
  • 10.1016/j.ajog.2015.11.024
  • 10.1016/j.ajog.2018.08.034
  • Melchiorre K, (1979), Hypertens (Dallas, Tex), 2011, pp. 85
  • 10.3109/10641955.2012.697951
  • Melchiorre K, (1979), Hypertens (Dallas, Tex), 2016, pp. 754
  • 10.1136/bmj.j3078
  • 10.1016/j.ajog.2015.12.047
  • 10.1161/HYPERTENSIONAHA.114.04850
  • 10.1016/j.tcm.2018.04.009
  • 10.1016/j.ajog.2016.02.003
  • 10.1016/j.ajog.2016.05.047
  • 10.1016/j.ajog.2017.02.015
  • 10.1016/j.ajog.2018.04.002
  • 10.1016/j.preghy.2014.02.001
  • 10.1081/PRG-120021060
  • Valensise H, (1979), Hypertens (Dallas, Tex), 2008, pp. 873
  • 10.1016/j.ajog.2015.08.003
  • Brosens IA, (1972), Obstet Gynecol Ann, 1, pp. 177
  • 10.1016/j.ajog.2010.08.009
  • 10.1016/j.ajog.2016.12.029
  • 10.1016/0002-9378(75)90522-0
  • 10.1111/j.1471-0528.1986.tb07830.x
  • 10.1136/heartjnl-2015-308476
  • 10.1093/bja/aei054
  • 10.1016/j.amjsurg.2008.07.039
  • 10.1002/uog.15884
  • 10.1002/uog.17287
  • Hypertension in pregnancy: diagnosis and management | Guidance and guidelines | NICE. [https://www.nice.org.uk/guidance/cg107/chapter/1‐guidance]. Accessed 1 November 2019.
  • 10.1111/j.1460-9592.2010.03480.x
  • 10.1177/1751143715619186
  • 10.1002/uog.15915
  • 10.1002/uog.17504
  • 10.1016/0002-9378(89)90901-0
  • Easterling TR, (1990), Obstet Gynecol, 76, pp. 1061
  • 10.1016/j.ajog.2018.07.029
  • 10.1016/S0002-9378(84)90357-0
  • 10.1161/01.HYP.17.6.1072
  • 10.1002/uog.18835
  • 10.1016/j.ajog.2007.11.014
  • 10.1016/j.ajog.2017.10.226
  • 10.1002/uog.20231
  • 10.1002/uog.19197
  • Tay J, (2018), Am J Obstet Gynecol, 218, pp. S745
  • 10.1016/0028-2243(93)90265-E
  • 10.1111/j.1479-828X.1999.tb03407.x
  • 10.1016/j.ajog.2004.08.035
  • 10.1161/HYPERTENSIONAHA.118.11092
  • 10.1016/S0002-9378(87)80172-2
  • 10.1016/j.ajog.2013.12.029
  • 10.1136/bmj.322.7291.912
  • Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba’aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 2006;194:921–31.
  • Egeland GM, Klungsøyr K, Øyen N, Tell GS, Næss Ø, Skjærven R. Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: Cohort Norway Study. Hypertens (Dallas, Tex 1979;2016:1173–80.
  • Sween LK, Althouse AD, Roberts JM. Early-pregnancy percent body fat in relation to preeclampsia risk in obese women. Am J Obstet Gynecol 2015;212: 84.e1–84.e7.
  • Durst JK, Tuuli MG, Stout MJ, Macones GA, Cahill AG. Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol 2016;214):651.e1–651.e5.
  • Sheen J-J, Wright JD, Goffman D, Kern-Goldberger AR, Booker W, Siddiq Z, et al. Maternal age and risk for adverse outcomes. Am J Obstet Gynecol 2018;219:390.e1–390.e15.
  • Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertens (Dallas, Tex) 1979;2011:85–93.
  • Melchiorre K, Sutherland GR, Watt-Coote I, Liberati M, Thilaganathan B. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy 2012;31:454–71.
  • Melchiorre K, Sharma R, Khalil A, Thilaganathan B. Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload. Hypertens (Dallas, Tex) 1979;2016:754–62.
  • Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ 2017;358:j3078.
  • Tooher J, Thornton C, Makris A, Ogle R, Korda A, Horvath J, et al. Hypertension in pregnancy and long-term cardiovascular mortality: a retrospective cohort study. Am J Obstet Gynecol 2016;214:722.e1– 722.e6.
  • Veerbeek JHW, Hermes W, Breimer AY, van Rijn BB, Koenen SV, Mol BW, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension novelty and significance. Hypertension 2015;65:600–6.
  • Perry H, Khalil A, Thilaganathan B. Preeclampsia and the cardiovascular system: an update. Trends Cardiovasc Med 2018;28:505–13.
  • White WM, Mielke MM, Araoz PA, Lahr BD, Bailey KR, Jayachandran M, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obstet Gynecol 2016;214:519.e1–519.e8.
  • Cain MA, Salemi JL, Tanner JP, Kirby RS, Salihu HM, Louis JM. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol 2016;215:484.e1–484.e14.
  • Bokslag A, Teunissen PW, Franssen C, van Kesteren F, Kamp O, Ganzevoort W, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol 2017;216:523.e1–523.e7.
  • Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW. Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am J Obstet Gynecol 2018;219:107.e1–107.e6.
  • Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens An Int J Women’s Cardiovasc Heal 2014;4:97–104.
  • von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8.
  • Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertens (Dallas, Tex) 1979;2008:873– 80.
  • Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol 2015;213:S9.e1–S9.e4.
  • Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1972;1:177–91.
  • Brosens I, Pijnenborg R, Vercruysse L, Romero R. The, “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193–201.
  • Labarrere CA, DiCarlo HL, Bammerlin E, Hardin JW, Kim YM, Chaemsaithong P, et al. Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. Am J Obstet Gynecol 2017;216:287.e1–287.e16.
  • De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975;123:164–74.
  • Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–59.
  • Meah VL, Cockcroft JR, Backx K, Shave R, Sto€hr EJ. Cardiac output and related haemodynamics during pregnancy: a series of meta- analyses. Heart 2016;102:518–26.
  • Tan HL, Pinder M, Parsons R, Roberts B, van Heerden PV. Clinical evaluation of USCOM ultrasonic cardiac output monitor in cardiac surgical patients in intensive care unit. Br J Anaesth 2005;94:287–91.
  • Jain S, Allins A, Salim A, Vafa A, Wilson MT, Margulies DR. Noninvasive Doppler ultrasonography for assessing cardiac function: can it replace the Swan-Ganz catheter? Am J Surg 2008;196:961–8.
  • Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016;48:333–9.
  • Poon LCY, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH. Birth weight in live births and stillbirths. Ultrasound Obstet Gynecol 2016;48:602–6.
  • Hypertension in pregnancy: diagnosis and management | Guidance and guidelines | NICE. [https://www.nice.org.uk/guidance/cg107/cha pter/1-guidance]. Accessed 1 November 2019.
  • Dhanani S, Barrowman NJ, Ward RE, Murto KT. Intra- and inter-observer reliability using a noninvasive ultrasound cardiac output monitor in healthy anesthetized children. Pediatr Anesth 2011;21:858–64.
  • Hodgson LE, Venn R, Forni LG, Samuels TL, Wakeling HG. Measuring the cardiac output in acute emergency admissions: use of the non-invasive ultrasonic cardiac output monitor (USCOM) with determination of the learning curve and inter-rater reliability. J Intensive Care Soc 2016;17:122.
  • Vinayagam D, Patey O, Thilaganathan B, Khalil A. Cardiac output assessment in pregnancy: comparison of two automated monitors with echocardiography. Ultrasound Obstet Gynecol 2017;49:32–8.
  • Vinayagam D, Thilaganathan B, Stirrup O, Mantovani E, Khalil A. Maternal hemodynamics in normal pregnancies: reference ranges and the role of maternal characteristics. Ultrasound Obstet Gynecol 2018;51:665–71.
  • Mabie WC, Ratts TE, Sibai BM. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol 1989;161(6 Pt 1):1443–8.
  • Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:1061–9.
  • Tay J, Foo L, Masini G, Bennett PR, Mceniery CM, Wilkinson IB, et al. Cardiac output in pre eclampsia is associated with the presence of fetal growth restriction, not gestation at onset: a prospective cohort study. Am J Obstet Gynecol 2018;219:627. Groenendijk R, Trimbos JBMJ, Wallenburg HCS. Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol 1984;150:232–6.
  • Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991;17 (6_pt_2):1072–7.
  • Stott D, Nzelu O, Nicolaides KH, Kametas NA. Maternal haemodynamics in normal pregnancies and in pregnancies affected by pre-eclampsia. Ultrasound Obstet Gynecol 2018;52:359– 64.
  • Rang S, van Montfrans GA, Wolf H. Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2008;198:519.e1–519.e9.
  • Ferrazzi E, Stampalija T, Monasta L, Di Martino D, Vonck S, Gyselaers W. Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy. Am J Obstet Gynecol 2018;218:124.e1–124.e11.
  • Bijl RC, Valensise H, Novelli GP, Vasapollo B, Wilkinson I, Thilaganathan B, et al. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics. Ultrasound Obstet Gynecol 2019;54:35–50.
  • Perry H, Lehmann H, Mantovani E, Thilaganathan B, Khalil A. Correlation between central and uterine haemodynamics in hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol 2019;54:58–63.
  • Tay J, Masini G, McEniery CM, Giussani DA, Shaw CJ, Wilkinson IB, et al. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function. Am J Obstet Gynecol 2018;218: S745–S761.
  • Olofsson P, Laurini RN, Mars´al K. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993;49:161– 8.
  • Sag˘ol S, Ozkinay E, Oztekin K, Ozdemir N. The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed. Aust N Z J Obstet Gynaecol 1999;39:324–9.
  • Spaanderman MEA, Willekes C, Hoeks APG, Ekhart THA, Aardenburg R, Courtar DA, et al. Maternal nonpregnant vascular function correlates with subsequent fetal growth. Am J Obstet Gynecol 2005;192:504–12. 50 Foo FL, Mahendru AA, Masini G, Fraser A, Cacciatore S, MacIntyre DA, et al. Association between prepregnancy cardiovascular function and subsequent preeclampsia or fetal growth restriction novelty and significance. Hypertension 2018;72:442–50.
  • Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol 1987;157:360–3.
  • Stevens DU, Al-Nasiry S, Fajta MM, Bulten J, van Dijk AP, van der Vlugt MJ, et al. Cardiovascular and thrombogenic risk of decidual vasculopathy in preeclampsia. Am J Obstet Gynecol 2014;210:545.e1–545.e6.
  • Beevers G, Lip GY, O’Brien E. ABC of hypertension: the pathophysiology of hypertension. BMJ 2001;322:912–6.